<PAGE>

-------------------------------------------------------------------------------
-------------------------------------------------------------------------------

                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                  FORM 10-K/A

  [X]            ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
                    OF THE SECURITIES EXCHANGE ACT OF 1934

                  For the fiscal year ended December 31, 2000

  [_]        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                      THE SECURITIES EXCHANGE ACT OF 1934

                 For the transition period from       to

                        Commission file number 0-19386

                          FISCHER IMAGING CORPORATION
            (Exact name of Registrant as specified in its charter)

<TABLE>
<CAPTION>
                  Delaware                                       36-2756787
<S>                                            <C>
          (State of incorporation)                  (I.R.S. Employer Identification No.)
          12300 North Grant Street
              Denver, Colorado                                     80241
  (Address of principal executive offices)                       (Zip Code)
</TABLE>

      Registrant's telephone number, including area code: (303) 452-6800

       Securities Registered Pursuant to Section 123(b) of the Act: None

          Securities Registered Pursuant to Section 12(g) of the Act:

                         Common Stock, Par Value $0.01
                                   Per Share

  Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports) and (ii) has been subject to
such filing requirements for the past 90 days.  Yes [X] No [_]

[X] Indicate by check mark if the disclosure of delinquent filers pursuant to
Item 405 of Regulation K-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of the Form 10-K or any
amendment to this Form 10-K.

  The aggregate market value of the common equity held by non-affiliates of
the Registrant as of March 1, 2001 was approximately $24,923,000.

  The number of shares of Registrants's Common Stock outstanding as of March
1, 2001 was 8,630,972.

                      DOCUMENTS INCORPORATED BY REFERENCE

  Portions of the Registrant's Proxy Statement for its 2000 Annual Meeting of
Stockholders to be filed on or prior to April 30, 2001, are incorporated by
reference into Part III of this Form 10-K.

-------------------------------------------------------------------------------
-------------------------------------------------------------------------------
<PAGE>

                                    PART IV

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K

  a) Documents filed as part of this report:

    1. Financial Statements.

      See pages F-3 through F-21 of this Form 10-K.

    2. Financial Statement Schedules.

      None.

    3. Exhibits.

      The following are filed as part of this report:

<TABLE>
<CAPTION>
 Exhibit
 Number                          Description of Exhibit
 -------                         ----------------------
 <C>     <S>
  3.1    Certificate of Incorporation of the Company(1)
  3.2    Bylaws of the Company(1)
  4.1    Amended and Restated Rights Agreement, dated as of November 3, 1994,
         between the Company and American Securities Transfer, Inc. which
         includes the Certificate of Designation for the Series C Junior
         Participating Preferred stock as Exhibit A and the form of Right
         Certificate as Exhibit B (4)
  4.2    Certificate of Designation for the Series D Convertible Preferred
         Stock(4)
 10.1    Agreement, dated October 5, 1990, between the Company and Dornier
         Medizintechnik GmbH (1)
 10.2    Purchase Agreement, dated August 29, 1994, between the Company and
         General Electric Company on behalf of GE Medical Systems(4)
 10.3    Nonemployee Director Stock Option Plan, as amended(5)
 10.4    Stock Option Plan(1)
 10.5    Retention Bonus Plan(3)
 10.6    Lease Agreement dated July 31, 1992 between the Company and JN
         Properties(2)
 10.7    Stock Purchase Agreement, dated as of June 20, 1995, between the
         Company and General Electric Company, acting through its GE Medical
         Systems Division, or GEMS(4)
 10.8    Registration Rights Agreement, dated as of June 20, 1995, between the
         Company and GEMS(4)
 10.9    Manufacturing and License Agreement, dated as of June 20, 1995,
         between the Company and GEMS(4)
 10.10   Amendment, dated as of June 20, 1995, to Purchase Agreement, dated as
         of August 29, 1994, between the Company and GEMS(4)
 10.11   Agreement dated October 10, 1997, between the Company and Ethicon
         Endo-Surgery, Inc. with Addendum dated January 29, 1998(5)
 21      List of Subsidiaries(6)
 23      Consent of Independent Public Accountants(7)
</TABLE>

--------
(1) Incorporated by reference to the Company's Registration Statement on Form
    S-1, File No. 33-41537, as filed with the Securities and Exchange
    Commission (the "Commission") on July 3, 1991.

                                       28
<PAGE>

(2) Incorporated by reference to the Company's Form 10-K for the year ended
    December 31, 1992, as filed with the Commission.

(3) Incorporated by reference to the Company's Form 10-K for the year ended
    December 31, 1994, as filed with the Commission on April 14, 1995.

(4) Incorporated by reference to the Company's Form 8-K, as filed with the
    Commission on July 3, 1995.

(5) Incorporated by reference to the Company's Form 10-K for the year ended
    December 31, 1997, as filed with the Commission on March 31, 1998.

(6) Previously filed.

(7) Filed herewith.

  b) Reports on Form 8-K

  None

  c) Exhibits

  See Item 14(a)(3) of this Form 10-K.

  d) Financial Statement Schedules

  None

                                       29
<PAGE>

                                  SIGNATURES

  Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be singed
on its behalf by the undersigned, thereunto duly authorized.

                                          FISCHER IMAGING CORPORATION

                                                 /s/ Rodney B. Johnson
Date: April 3, 2001                       By: _________________________________
                                                     Rodney B. Johnson
                                                VP Finance, Chief Financial
                                                   Officer, and Secretary



                                      30